RARE

$0.00

(

+0.00%

)
Quote details

stock

Ultragenyx

NASDAQ | RARE

32.02

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$3.03B

Market Cap

-

P/E Ratio

-5.48

EPS

$57.99

52 Week High

$25.81

52 Week Low

HEALTHCARE

Sector

RARE Chart

Recent Chart
Price Action

RARE Technicals

Tags:

RARE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $484M
Total Revenue $560M
Cost Of Revenue $77M
Costof Goods And Services Sold $77M
Operating Income -$536M
Selling General And Administrative $322M
Research And Development $698M
Operating Expenses $1B
Investment Income Net -
Net Interest Income -$27M
Interest Income $37M
Interest Expense $63M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $36M
Income Before Tax -$568M
Income Tax Expense $1.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$569M
Comprehensive Income Net Of Tax -
Ebit -$505M
Ebitda -$469M
Net Income -$569M

Revenue & Profitability

Earnings Performance

RARE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.5B
Total Current Assets $817M
Cash And Cash Equivalents At Carrying Value $174M
Cash And Short Term Investments $174M
Inventory $45M
Current Net Receivables $122M
Total Non Current Assets $686M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $178M
Intangible Assets Excluding Goodwill $178M
Goodwill $44M
Investments -
Long Term Investments $135M
Short Term Investments $436M
Other Current Assets $40M
Other Non Current Assets -
Total Liabilities $1.2B
Total Current Liabilities $344M
Current Accounts Payable $39M
Deferred Revenue -
Current Debt -
Short Term Debt $21M
Total Non Current Liabilities $897M
Capital Lease Obligations $40M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $910M
Other Current Liabilities $245M
Other Non Current Liabilities $17M
Total Shareholder Equity $255M
Treasury Stock -
Retained Earnings -$4B
Common Stock $92K
Common Stock Shares Outstanding $91M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$414M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $36M
Capital Expenditures $7.5M
Change In Receivables -
Change In Inventory -$11M
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $399M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$569M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $484M
Total Revenue $560M
Cost Of Revenue $77M
Costof Goods And Services Sold $77M
Operating Income -$536M
Selling General And Administrative $322M
Research And Development $698M
Operating Expenses $1B
Investment Income Net -
Net Interest Income -$27M
Interest Income $37M
Interest Expense $63M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $36M
Income Before Tax -$568M
Income Tax Expense $1.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$569M
Comprehensive Income Net Of Tax -
Ebit -$505M
Ebitda -$469M
Net Income -$569M

RARE News

RARE Profile

Ultragenyx Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Ultragenyx Pharmaceutical Inc. (RARE) is a leading biopharmaceutical firm dedicated to the advancement of innovative therapies for patients suffering from rare and ultra-rare genetic disorders. With its headquarters in Novato, California, the company is committed to addressing significant unmet medical needs through a robust pipeline of product candidates, which includes both gene therapy and enzyme replacement therapies. Ultragenyx employs a patient-centric approach, ensuring that the development and commercialization of its therapies align with the needs of the rare disease community. The company aims to provide transformative treatment options that can enhance and prolong the lives of individuals affected by these complex conditions.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
SNAP
-7.15%
$7.78
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.18%
$11.54
CLF
+4.93%
$13.83
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
PFE
-1.82%
$24.78
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+31.03%
$2.66
ONDS
+17.24%
$10.81
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IREN
+7.31%
$64.14
ABAT
+36.59%
$9.22
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
NOK
-1.31%
$5.25
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
UAMY
+36.85%
$16.71
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
BMNR
+8.34%
$56.85
RMBL
+60.50%
$3.21
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAPL
+0.97%
$247.66
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.08%
$25.59
RF
+1.65%
$24.56
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
NB
+8.95%
$11.32
GDXD
-13.62%
$0.73
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
VZ
-0.27%
$39.74
OKLO
+16.20%
$171.00
RIOT
+3.28%
$21.70
PMAX
+44.78%
$3.75
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
SNAP
-7.15%
$7.78
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.18%
$11.54
CLF
+4.93%
$13.83
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
PFE
-1.82%
$24.78
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+31.03%
$2.66
ONDS
+17.24%
$10.81
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IREN
+7.31%
$64.14
ABAT
+36.59%
$9.22
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
NOK
-1.31%
$5.25
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
UAMY
+36.85%
$16.71
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
BMNR
+8.34%
$56.85
RMBL
+60.50%
$3.21
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAPL
+0.97%
$247.66
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.08%
$25.59
RF
+1.65%
$24.56
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
NB
+8.95%
$11.32
GDXD
-13.62%
$0.73
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
VZ
-0.27%
$39.74
OKLO
+16.20%
$171.00
RIOT
+3.28%
$21.70
PMAX
+44.78%
$3.75

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.